Butterfly Network Pre-Announces Q4 2025 Revenue Growth of At Least 17%, Citing Strong Momentum
Summary
Butterfly Network announced preliminary Q4 2025 revenue growth of at least 17% year-over-year, with management expressing confidence in continued growth and strategic expansion for 2026.
Key Events
-
Preliminary Q4 2025 Revenue Growth
Butterfly Network expects to report revenue growth of at least 17% year-over-year for the fourth quarter ended December 31, 2025.
-
Positive Business Outlook for 2026
CEO Joseph DeVivo highlighted strong momentum, continued growth in the handheld ultrasound business, and anticipated a "meaningful inflection year" in 2026 through scaling core commercial operations and expanding Ultrasound-on-Chip™ and semiconductor co-development and licensing.
-
Upcoming Conference Presentation
CEO Joseph DeVivo will present a business update at the 44th J.P. Morgan Healthcare Conference on January 15, 2026, where he will outline the company's 2026 strategy.
Analysis
The preliminary announcement of at least 17% year-over-year revenue growth for Q4 2025 indicates strong performance for Butterfly Network. Management's commentary highlights positive momentum, with the CEO anticipating a "meaningful inflection year" in 2026 driven by core commercial business scaling and expansion into Ultrasound-on-Chip™ and semiconductor co-development and licensing. This suggests a positive outlook for future growth and strategic diversification, which could be a significant catalyst for the company. Investors will be looking for further details and 2026 guidance during the upcoming J.P. Morgan Healthcare Conference presentation and the full Q4 earnings report in late February.
At the time of this filing, BFLY was trading at $4.04 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1B. The 52-week trading range was $1.32 to $4.98. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.